Operable breast cancer: a review of neoadjuvant chemotherapy.
Neoadjuvant chemotherapy in operable breast carcinoma (Ia-IIb) may influence the disease development reducing recurrence rate. A survey was conducted from 1975 to 1989 in an attempt to evaluate if pre- and peri-operative chemotherapy is able to improve the survival rate. However, available literature shows that only some Authors observed an increased disease free-survival rate among N- patients.
Volpe
T
T
Dipartimento di Ginecologia Oncologia, Università degli Studi di Torino.
Ferrero
A
A
Bau
M G
MG
Zola
P
P
Sismondi
P
P
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015996:Survival Rate